We are live on
!
Find out more
EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
EPRS
Delisted
EPRS was delisted on the 3rd of August, 2016.
41 hedge funds and large institutions have $64.9M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 41 → 41 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
20% less capital invested
Capital invested by funds: $81M → $64.9M (-$16.1M)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $494K
Holders
41
Holders Change
–
Holders Change %
0%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
9
Reduced
12
Closed
11
Calls
–
Puts
$494K
Net Calls
-$494K
Net Calls Change
-$495K
Top Buyers
| 1 |
Millennium Management
New York
|
+$2.23M |
| 2 |
B
Bailard
Foster City,
California
|
+$796K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$386K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$376K |
| 5 |
CCM
Consonance Capital Management
New York
|
+$345K |
